NPT-IIb Inhibition Does Not Improve Hyperphosphatemia in CKD
Keywords: محاکمه فاز 1; end-stage renal disease; hemodialysis; hyperphosphatemia; NPT-IIb inhibitor; pharmacokinetics; phase 1 trial;